Clinical Trial Update: Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a higher dose of Somatropin to the label dose in early-pubertal children with growth hormone deficiency; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2009-06-08